Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial

Arthritis &Rheumatology, Volume 78, Issue 3, Page 752-762, March 2026.

Criar conta gratuita para acessar o conteúdo completo